Correlation Between Krystal Biotech and Propanc Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Krystal Biotech and Propanc Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krystal Biotech and Propanc Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Krystal Biotech and Propanc Biopharma, you can compare the effects of market volatilities on Krystal Biotech and Propanc Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krystal Biotech with a short position of Propanc Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krystal Biotech and Propanc Biopharma.

Diversification Opportunities for Krystal Biotech and Propanc Biopharma

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Krystal and Propanc is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Krystal Biotech and Propanc Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Propanc Biopharma and Krystal Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krystal Biotech are associated (or correlated) with Propanc Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Propanc Biopharma has no effect on the direction of Krystal Biotech i.e., Krystal Biotech and Propanc Biopharma go up and down completely randomly.

Pair Corralation between Krystal Biotech and Propanc Biopharma

Given the investment horizon of 90 days Krystal Biotech is expected to generate 1.37 times less return on investment than Propanc Biopharma. But when comparing it to its historical volatility, Krystal Biotech is 6.29 times less risky than Propanc Biopharma. It trades about 0.07 of its potential returns per unit of risk. Propanc Biopharma is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  30.00  in Propanc Biopharma on August 27, 2024 and sell it today you would lose (29.97) from holding Propanc Biopharma or give up 99.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Krystal Biotech  vs.  Propanc Biopharma

 Performance 
       Timeline  
Krystal Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Krystal Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Krystal Biotech is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.
Propanc Biopharma 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Propanc Biopharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain fundamental indicators, Propanc Biopharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Krystal Biotech and Propanc Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Krystal Biotech and Propanc Biopharma

The main advantage of trading using opposite Krystal Biotech and Propanc Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krystal Biotech position performs unexpectedly, Propanc Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Propanc Biopharma will offset losses from the drop in Propanc Biopharma's long position.
The idea behind Krystal Biotech and Propanc Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings